[ad_1]
Scientists have warned that the first Corona virus vaccine, “the Oxford vaccine,” will not be a “silver bullet” and is unlikely to prevent people from contracting the disease, a blow to the world’s hopes. to avoid the second severe lockdown, according to the Daily Mail.
Experts who advised the government said the first vaccine can only reduce people’s symptoms and be partially effective, as they emphasize the need to be careful before releasing the vaccine to people.
England’s chief medical officer, Professor Chris Whitty, confirmed that the vaccine’s efficacy level will range between 40-60% similar to that of the influenza vaccine, but the Oxford University team leading the responsibility for the vaccine has set a target of a minimum of 50%.
They said that something that could cut coronavirus cases in half would be of great value, but this means that millions of people, in theory, would still be susceptible to this life-threatening disease.
Wellcome vaccination officer Charlie Wheeler said the first vaccine may need to be scaled up along with other restrictions.
He added: “There is a lot of hope, which is understandable, is that one dose of the vaccine will give us complete immunity for life and return us to normal life the next day, but this will not be the best solution; the vaccine will not be a miracle solution. “
British scientists had revealed the implementation of an exciting study to speed up vaccine trials, known as the ‘challenge trial’, which is based on the infection of participants with the Corona virus one month after being vaccinated instead of wait for them to become infected naturally.
"); //}, 3000);}}); //$(window).bind('scroll '); $ (window) .scroll (function () {if (alreadyLoaded_facebookConnect == false) {alreadyLoaded_facebookConnect = true ; // $ (window) .unbind ('scroll'); // console.log ("scroll loaded"); (function (d, s, id) {var js, fjs = d.getElementsByTagName (s)[0]; if (d.getElementById (id)) return; js = d.createElement (s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore (js, fjs); } (document, 'script', 'facebook-jssdk')); // pre_loader (); // $ (window) .unbind ('mousemove'); // setTimeout (function () {// $ ('# boxTwitter'). html ("Tweets from @tayyar_org"); //}, 3000); var scriptTag = document.createElement (" script "); scriptTag.type =" text / javascript "scriptTag.src =" https://news.google.com/scripts/social. js "; scriptTag.async = true; document.getElementsByTagName (" head ")[0].appendChild (scriptTag); (function () {$ .getScript ("https://news.google.com/scripts/social.js", function () {});}); }}); //$(window).load(function () {// setTimeout (function () {// // add the returned content to a newly created script tag // var se = document.createElement ('script'); / / se.type = "text / javascript"; // //se.async = true; // se.text = "setTimeout (function () {pre_loader ();}, 5000);"; // document. getElementsByTagName ('body')[0].appendChild (se); //}, 5000); //});
[ad_2]
